Pancreatic Cancer Research

ResearcherThe Affiliated Yongchuan Hospital of Chongqing Medical UniversityActive in the last 2 years

Hongfan Liao

Matched on ORCID iD 0000-0002-0574-6421; OpenAlex author ID A5011182090. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 3 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers

Papers 7

  1. Targeting MYOF suppresses pancreatic ductal adenocarcinoma progression by inhibiting ILF3-LCN2 signaling through disrupting OTUB1-mediated deubiquitination of … Co-author DOI 10.1016/j.redox.2025.103665↗
  2. Preoperative risk stratification of early recurrence in resected pancreatic ductal adenocarcinoma: Novel equilibrium-phase-computed tomography biomarker of ext… Co-author DOI 10.3748/wjg.v31.i35.109687↗
  3. One novel transfer learning-based CLIP model combined with self-attention mechanism for differentiating the tumor-stroma ratio in pancreatic ductal adenocarcin… Co-author DOI 10.1007/s11547-024-01902-y↗
  4. Feasibility and effectiveness of automatic deep learning network and radiomics models for differentiating tumor stroma ratio in pancreatic ductal adenocarcinom… Co-author DOI 10.1186/s13244-023-01553-z↗
  5. Dual-energy CT with virtual monoenergetic images and iodine maps improves tumor conspicuity in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13244-022-01297-2↗
  6. One 3D VOI-based deep learning radiomics strategy, clinical model and radiologists for predicting lymph node metastases in pancreatic ductal adenocarcinoma bas… Co-author DOI 10.3389/fonc.2022.990156↗
  7. Comparison of Multiple Radiomics Models for Identifying Histological Grade of Pancreatic Ductal Adenocarcinoma Preoperatively Based on Multiphasic Contrast-Enh… Co-author DOI 10.3390/diagnostics12081915↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongmei Li · 6 shared papers, 2022–2025 · strength 1.18
  2. Yanbing Liu · 3 shared papers, 2022–2023 · strength 0.53
  3. Hongwei Liang · 1 shared paper, 2025 · strength 0.28
  4. Zhiwei Zhang · 1 shared paper, 2025 · strength 0.28
  5. Nan Li · 1 shared paper, 2025 · strength 0.22
  6. Zhihui Li · 1 shared paper, 2025 · strength 0.22
  7. Hongwei Liang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.